184 related articles for article (PubMed ID: 7493344)
41. Targeting of liver metastases of colorectal cancer with IgG, F(ab')2, and Fab' anti-carcinoembryonic antigen antibodies labeled with 99mTc: the role of metabolism and kinetics.
Behr T; Becker W; Hannappel E; Goldenberg DM; Wolf F
Cancer Res; 1995 Dec; 55(23 Suppl):5777s-5785s. PubMed ID: 7493346
[TBL] [Abstract][Full Text] [Related]
42. Antitumor activity of Fab' and IgG-anti-CD22 immunotoxins in disseminated human B lymphoma grown in mice with severe combined immunodeficiency disease: effect on tumor cells in extranodal sites.
Ghetie MA; Richardson J; Tucker T; Jones D; Uhr JW; Vitetta ES
Cancer Res; 1991 Nov; 51(21):5876-80. PubMed ID: 1933855
[TBL] [Abstract][Full Text] [Related]
43. Technetium-99m HM-PAO-labeled leukocytes in detection of inflammatory lesions: comparison with gallium-67 citrate.
Vorne M; Soini I; Lantto T; Paakkinen S
J Nucl Med; 1989 Aug; 30(8):1332-6. PubMed ID: 2754489
[TBL] [Abstract][Full Text] [Related]
44. Initial experience in treating human lymphoma with a combination of bispecific antibody and saporin.
Bonardi MA; Bell A; French RR; Gromo G; Hamblin T; Modena D; Tutt AL; Glennie MJ
Int J Cancer Suppl; 1992; 7():73-7. PubMed ID: 1428411
[TBL] [Abstract][Full Text] [Related]
45. Treatment of B-cell lymphomas with combination of bispecific antibodies and saporin.
French RR; Hamblin TJ; Bell AJ; Tutt AL; Glennie MJ
Lancet; 1995 Jul; 346(8969):223-4. PubMed ID: 7542357
[TBL] [Abstract][Full Text] [Related]
46. Internalization and intracellular processing of an anti-B-cell lymphoma monoclonal antibody, LL2.
Shih LB; Lu HH; Xuan H; Goldenberg DM
Int J Cancer; 1994 Feb; 56(4):538-45. PubMed ID: 8112889
[TBL] [Abstract][Full Text] [Related]
47. Treatment of SCID/human B cell precursor ALL with anti-CD19 and anti-CD22 immunotoxins.
Herrera L; Yarbrough S; Ghetie V; Aquino DB; Vitetta ES
Leukemia; 2003 Feb; 17(2):334-8. PubMed ID: 12592332
[TBL] [Abstract][Full Text] [Related]
48. Comparison of 67Ga-citrate, 111In-bleomycin and 99mTc-citrate in the evaluation of pulmonary lesions.
Apostolidis P; Kostaki P; Hatzigeorgiou N; Skambardonis N; Giavroglou J; Salem N
Eur J Nucl Med; 1980; 5(1):57-61. PubMed ID: 6155268
[TBL] [Abstract][Full Text] [Related]
49. Evaluation of ricin A chain-containing immunotoxins directed against CD19 and CD22 antigens on normal and malignant human B-cells as potential reagents for in vivo therapy.
Ghetie MA; May RD; Till M; Uhr JW; Ghetie V; Knowles PP; Relf M; Brown A; Wallace PM; Janossy G
Cancer Res; 1988 May; 48(9):2610-7. PubMed ID: 2451562
[TBL] [Abstract][Full Text] [Related]
50. The role of gallium 67 imaging in non-Hodgkin's lymphoma of the gastrointestinal tract.
Kataoka M; Kawamura M; Tsuda T; Itoh H; Komatsu A; Tanada S; Iio A; Hamamoto K
Eur J Nucl Med; 1990; 17(3-4):142-7. PubMed ID: 2279495
[TBL] [Abstract][Full Text] [Related]
51. A phase I study of combination therapy with immunotoxins IgG-HD37-deglycosylated ricin A chain (dgA) and IgG-RFB4-dgA (Combotox) in patients with refractory CD19(+), CD22(+) B cell lymphoma.
Messmann RA; Vitetta ES; Headlee D; Senderowicz AM; Figg WD; Schindler J; Michiel DF; Creekmore S; Steinberg SM; Kohler D; Jaffe ES; Stetler-Stevenson M; Chen H; Ghetie V; Sausville EA
Clin Cancer Res; 2000 Apr; 6(4):1302-13. PubMed ID: 10778955
[TBL] [Abstract][Full Text] [Related]
52. Tc-99m LL-2 Fab' monoclonal antibody imaging in acquired immune deficiency syndrome-related lymphoma.
Kramer EL; Volm M; Donahue B; Wasserheit C; Chapnick J; Sanger J; Koslow M
Cancer; 1997 Dec; 80(12 Suppl):2469-77. PubMed ID: 9406697
[TBL] [Abstract][Full Text] [Related]
53. Lung inflammation in coal miners assessed by uptake of 67Ga-citrate and clearance of inhaled 99mTc-labeled diethylenetriamine pentaacetate aerosol.
Susskind H; Rom WN
Am Rev Respir Dis; 1992 Jul; 146(1):47-52. PubMed ID: 1626813
[TBL] [Abstract][Full Text] [Related]
54. Comparative studies of radiocitrates in oncological models--I. 99mTc citrate and 67Ga citrate uptake by EMT-6 tumors in mice.
Gati LJ; Wiebe LI; Tse JW; Turner CJ; Noujaim AA
Int J Rad Appl Instrum B; 1986; 13(3):253-5. PubMed ID: 3464579
[TBL] [Abstract][Full Text] [Related]
55. Gallium-67-citrate scintigraphy of high-grade T-cell non-Hodgkin's lymphoma.
Lipp RW; Sill H; Aigner R; Ranner G; Hoefler G; Passath A; Leb G
J Nucl Med; 1996 Sep; 37(9):1524-5. PubMed ID: 8790208
[TBL] [Abstract][Full Text] [Related]
56. Revisiting the prognostic role of gallium scintigraphy in low-grade non-Hodgkin's lymphoma.
Gallamini A; Biggi A; Fruttero A; Pugno F; Cavallero G; Pregno P; Grasso M; Farinelli C; Leone A; Gallo E
Eur J Nucl Med; 1997 Dec; 24(12):1499-506. PubMed ID: 9391185
[TBL] [Abstract][Full Text] [Related]
57. Epratuzumab, a humanized monoclonal antibody targeting CD22: characterization of in vitro properties.
Carnahan J; Wang P; Kendall R; Chen C; Hu S; Boone T; Juan T; Talvenheimo J; Montestruque S; Sun J; Elliott G; Thomas J; Ferbas J; Kern B; Briddell R; Leonard JP; Cesano A
Clin Cancer Res; 2003 Sep; 9(10 Pt 2):3982S-90S. PubMed ID: 14506197
[TBL] [Abstract][Full Text] [Related]
58. Final results of a phase I radioimmunotherapy trial using (186)Re-epratuzumab for the treatment of patients with non-Hodgkin's lymphoma.
Postema EJ; Raemaekers JM; Oyen WJ; Boerman OC; Mandigers CM; Goldenberg DM; van Dongen GA; Corstens FH
Clin Cancer Res; 2003 Sep; 9(10 Pt 2):3995S-4002S. PubMed ID: 14506199
[TBL] [Abstract][Full Text] [Related]
59. Monoclonal antibodies in the treatment of non-Hodgkin's lymphoma: recent results and future prospects.
Renner C; Trümper L; Pfreundschuh M
Leukemia; 1997 Apr; 11 Suppl 2():S55-9. PubMed ID: 9178842
[TBL] [Abstract][Full Text] [Related]
60. The role of high dose 67-gallium scintigraphy in staging untreated patients with lymphoma.
Larcos G; Farlow DC; Antico VF; Gruenewald SM; Boyages J
Aust N Z J Med; 1994 Feb; 24(1):5-8. PubMed ID: 8002858
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
